Related references
Note: Only part of the references are listed.Role of metformin in inhibiting estrogen-induced proliferation and regulating ER alpha and ER beta expression in human endometrial cancer cells
Jingbo Zhang et al.
ONCOLOGY LETTERS (2017)
Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production
Angela Mogavero et al.
SCIENTIFIC REPORTS (2017)
Treatment of Pediatric Type 2 Diabetes
Jennifer D. Smith et al.
ANNALS OF PHARMACOTHERAPY (2016)
Environment Dictates Dependence on Mitochondrial Complex I for NAD plus and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
Dan Y. Gui et al.
Cell Metabolism (2016)
Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells
Nicole M. A. White-Al Habeeb et al.
PROSTATE (2016)
The insulin sensitiser metformin regulates chicken Sertoli and germ cell populations
M. Faure et al.
REPRODUCTION (2016)
Effects of metformin on energy intake and satiety in obese children
M. A. Adeyemo et al.
DIABETES OBESITY & METABOLISM (2015)
AMPK: a cellular energy sensor primarily regulated by AMP
Graeme J. Gowans et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Systematic Review of Metformin Use in Obese Nondiabetic Children and Adolescents
Claudia Brufani et al.
HORMONE RESEARCH IN PAEDIATRICS (2013)
Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo
Xianbin Cai et al.
ONCOLOGY REPORTS (2013)
Signal transduction pathways in FSH regulation of rat Sertoli cell proliferation
Maria F. Riera et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation
Arron Sikka et al.
CELL CYCLE (2012)
In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma
Zhan Qu et al.
HEPATOLOGY RESEARCH (2012)
Metformin exposure affects human and mouse fetal testicular cells
P. Tartarin et al.
HUMAN REPRODUCTION (2012)
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
R. Rattan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Activin A, a product of fetal Leydig cells, is a unique paracrine regulator of Sertoli cell proliferation and fetal testis cord expansion
Denise R. Archambeault et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
Mahvash Zakikhani et al.
CANCER PREVENTION RESEARCH (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis
A. Isakovic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
AMP-activated protein kinase - development of the energy sensor concept
D. Grahame Hardie et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Thyroid hormone, retinoic acid, and testosterone suppress proliferation and induce markers of differentiation in cultured rat Sertoli cells
JJ Buzzard et al.
ENDOCRINOLOGY (2003)
Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood
RM Sharpe et al.
REPRODUCTION (2003)
Regulation of rat sertoli cell function by FSH: possible role of phosphatidylinositol 3-kinase/protein kinase B pathway
SB Meroni et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Effect of metformin in pediatric patients with type 2 diabetes - A randomized controlled trial
KL Jones et al.
DIABETES CARE (2002)
The ERK-dependent signalling is stage-specifically modulated by FSH, during primary Sertoli cell maturation
P Crépieux et al.
ONCOGENE (2001)